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role of apoptosis during early brain morphogenesis is to ensure the
completion of neural tube closure.
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The cerebellum is derived from dorsal rhombomere 1 in the
embryo. Previous studies have demonstrated the importance of FGF
signals for the maintenance and patterning of r1 in the early embryo.
Three Sprouty genes (Spry1, Spry2 and Spry4), which encode
feedback antagonists of FGF signalling, are expressed in the mid-
hindbrain (MH) organiser and MH-specific Spry1;2 and Spry1;2;4
knockout embryos exhibit enlarged cerebellar primordia (r1) due to
increased FGF signalling. We also observed FGF and Sprouty gene
expression during later stages of cerebellar development, implying
roles for these genes in precursors of various cerebellar cell types
such as Bergmann glia, granule and Purkinje neurons. In support of
this idea, MH-specific Spry1;2 and Spry1;2;4 knockout cerebella
analysed at postnatal day (P)21 have fewer granule neurons and
abnormal foliation. The expression of FGF target genes, Pea3 and Erm
are increased, and SHH target genes, Gli1 and Ptch1 are decreased in
P7 mutant cerebella. The phenotype of Sprouty mutant can be
rescued by reducing FGF receptor 1 and Ptch1 gene dosage, providing
genetic proof that the cerebellar defects in Sprouty knockouts are due
to deregulated FGF and SHH signalling. Cell type-specific conditional
gene knockout experiments suggest that Sprouty gene function is
required in several cerebellar cell types during development.
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Loss of endocytic receptor LRP2/megalin in mice impairs specifi-
cation of the developing CNS, leading to holoprosencephaly. This
phenotype results from impaired morphogen signaling in the early
rostral forebrain organizer indicating an important function for LRP2
in neurulation (see abstract by Annabel Christ). Since expression of
Lrp2 persists throughout embryonic development, we wanted to test
whether the receptor may also have additional functions in later
stages of brain formation. Employing Foxg1cre-mediated conditional
recombination, we generated mice lacking LRP2 in the telencephalon
from embryonic day 9.5 onwards. Conditional Lrp2mutants showed a
reduced thickness of the basal telencephalon and an expansion of the
telencephalic vesicles. We did not observe loss of distinct differen-
tiated cell types but an overall reduced proliferation in the ventral
telencephalon. The rate of apoptosis was unchanged. Remarkably, loss
of LRP2 after neurulation in the embryonic telencephalon did not
affect the SHH or BMP4 pathways, which are severely compromised in
constitutive Lrp2 mutants. Rather, conditional LRP2 deficiency
specifically exhibited dorsal expansion of Fgf8 and Fgf17 gene
expression domains in the rostral forebrain. FGF signaling has been
previously implicated in the regulation of proliferation in rostroven-
tral telencephalon. We thus identified a late developmental role for
LRP2 in maintaining proliferation and correct expansion of the basal
telencephalon, likely mediated by FGF signaling.
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Using a mouse strain isolated during an ethyl-nitrosourea (ENU)
screen for recessive point mutations affecting midgestation morphol-
ogy, we identified a role for apoptotic peptidase activating factor 1
(Apaf1) during craniofacial development. Apaf1 is a key component of
the mitochondria-mediated apoptotic pathway, functioning upstream
of caspases 9 and 3. Interestingly, mice lacking caspase 9 or 3 do not
exhibit craniofacial defects in their phenotypes, demonstrating a
novel contribution of Apaf1 to facial development. Twenty percent of
our mutant mice show craniofacial abnormalities (wide frontonasal
prominence, cleft face, short/broad nasal region) by embryonic day
12.5. We observe these defects as early as embryonic day 10; they
vary in severity, and persist until birth – at which point we see skull
defects (in the frontal, nasal, and maxilla/premaxilla bones). Our
mutant allele is due to a T to C transition in exon 8 of Apaf1, resulting
in a proline substitution at a highly conserved leucine (L375P). We
found this is a critical residue as protein levels are unaffected in our
mutants. Furthermore, our Apaf1 allele phenocopies targeted Apaf1-
null alleles and fails to complement a spontaneous mutant that is
functionally deficient in Apaf1. Taken together our analyses of this
novel allele of Apaf1 identify a previously unrecognized residue that
is important for Apaf1 function, and provide evidence for a caspase-
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The development of the lower jaw is regulated spatiotemporally
by signaling cascades, and is refined through both permissive and
inhibitory signals. We have shown that endothelin-A receptor
(Ednra) signaling is a central regulator of lower jaw identity,
establishing the identity of cranial neural crest cells (NCCs) in the
mandibular arch through a mechanism involving Dlx5 and Dlx6
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